Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

5articles mentioning drugs

21drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: 3TC ×

3TC

This drug is selected. Its supporting articles are shown below.

3TC5

Articles mentioning 3TC

5 articles · page 1 of 1

OC36 Durability of bictegravir/emtricitabine/tenofovir alafenamide vs dolutegravir-based single tablet regimens in a large cohort of experienced PWH: the BIC-LASTING study

sextrans · abstract · 2026-06-05 · 7 matching annotations

85.2%

dolutegravir bictegravir emtricitabine DTG tenofovir alafenamide abacavir 3TC rilpivirine DTG-STR lamivudine

…ctegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) vs. dolutegravir (DTG)-based single tablet regimens (STR) on treatment failure-r…

P106 Retrospective evaluation of lamivudine prophylaxis for prevention of hepatitis B virus reactivation in hematologic patients undergoing chemotherapy (REPLAY): a single-center experience

sextrans · abstract · 2026-05-20 · 7 matching annotations

95.8%

3TC entecavir tenofovir ETV TDF lamivudine HBVr SC Ematologia IRCCS Policlinico San Matteo

…logical response, defined as undetectable HBVDNA.In this study, 3TC prophylaxis was safe and associated with a low rate of HBVr in …

P20 B/F/TAF vs DTG: similar durability, different reasons for discontinuation. results of a real-life study

sextrans · abstract · 2026-05-20 · 4 matching annotations

91.1%

Dolutegravir bictegravir darunavir abacavir atazanavir rilpivirine 3TC lamivudine emtricitabine DTG+1 more

…ain characteristics of 2359 PWH enrolled in the Bictegravir and Dolutegravir SCOLTA cohortsAbstract P20 Table 2Reasons for 568 discontinuati…

Doravirine versus dolutegravir-based regimen in antiretroviral treatment-naive people living with HIV-1 (ANRS0392s ELDORADO): protocol for an international, open-label, randomised, non-inferiority, phase III trial

bmjopen · abstract · 2026-02-05 · 2 matching annotations

89.5%

DTG DOlutegravir 3TC TDF emtricitabine lamivudine doravirine FTC DTG-based DOR+3 more

…te (TDF) (300 mg daily) plus lamivudine (3TC) (300 mg daily) or DTG (50 mg daily) in combination with TDF (300 mg once daily) plus …

Acute hepatitis B following a switch to long-acting cabotegravir plus rilpivirine in an individual with a history of hepatitis B vaccination

sextrans · abstract · 2026-01-16 · 1 matching annotations

79.0%

emtricitabine lamivudine cabotegravir tenofovir 3TC rilpivirine FTC HIV hepatitis B virus hepatitis B+1 more

…. Unlike regimens containing tenofovir with lamivudine (3TC) or emtricitabine (FTC), it lacks therapeutic activity against the hepatitis B vi…